Illumina

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Illumina and other ETFs, options, and stocks.

About ILMN

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields, and enables the adoption of a variety of genomic solutions. 

CEO
Jacob Thaysen
CEOJacob Thaysen
Employees
12,010
Employees12,010
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
1998
Founded1998
Employees
12,010
Employees12,010

ILMN Key Statistics

Market cap
18.77B
Market cap18.77B
Price-Earnings ratio
-16.11
Price-Earnings ratio-16.11
Dividend yield
Dividend yield
Average volume
1.64M
Average volume1.64M
High today
$119.15
High today$119.15
Low today
$115.73
Low today$115.73
Open price
$116.25
Open price$116.25
Volume
829.49K
Volume829.49K
52 Week high
$232.23
52 Week high$232.23
52 Week low
$89.00
52 Week low$89.00

ILMN News

Benzinga 2d
What the Options Market Tells Us About Illumina - Illumina - Benzinga

Loading... Loading... Deep-pocketed investors have adopted a bearish approach towards Illumina ILMN, and it's something market players shouldn't ignore. Our tr...

What the Options Market Tells Us About Illumina - Illumina - Benzinga
Yahoo Finance 3d
European Commission approves Illumina's proposed Grail split - Yahoo Finance

Dive Brief: The European Commission has approved Illumina's planned divestment of Grail, the sequencing company said Friday, although no divestment plan has be...

European Commission approves Illumina's proposed Grail split - Yahoo Finance
Benzinga 6d
Looking Into Illumina's Recent Short Interest - Illumina - Benzinga

Loading... Loading... Illumina's ILMN short percent of float has risen 5.16% since its last report. The company recently reported that it has 5.21 million shar...

Looking Into Illumina's Recent Short Interest - Illumina - Benzinga

Analyst ratings

50%

of 26 ratings
Buy
38.5%
Hold
50%
Sell
11.5%

More ILMN News

TipRanks 6d
Illumina $1B cash outlay for Grail divestment ‘better than fears,’ says Evercore

After Illumina announced it has received approval of its divestment plan for GRAIL from the European Commission, Evercore ISI analyst Vijay Kumar said that rela...

TipRanks 6d
Illumina Gains Approval for GRAIL Divestiture Plans - TipRanks.com - TipRanks

Illumina (ILMN) has issued an announcement. Illumina, Inc. has received the green light from the European Commission to move forward with its divestment plan f...

Yahoo Finance 6d
Illumina's planned divestment of GRAIL approved by the European Commission - Yahoo Finance

SAN DIEGO, April 12, 2024 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced it has...

Illumina's planned divestment of GRAIL approved by the European Commission - Yahoo Finance
Reuters 6d
UPDATE 1-EU approves Illumina's plan to divest cancer test maker Grail

(Adds the European Commission comments, details) By Foo Yun Chee BRUSSELS, April 12 (Reuters) - U.S. gene sequencing company Illumina's plan to divest cancer...

UPDATE 1-EU approves Illumina's plan to divest cancer test maker Grail
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.